Evolution of the Average Target: GlaxoSmithKline Pakistan Limited

Evolution of the Average Target - GlaxoSmithKline Pakistan Limited

Evolution of the Target Price: GlaxoSmithKline Pakistan Limited

Evolution of the Target Price - GlaxoSmithKline Pakistan Limited

Changes in Analyst Recommendations: GlaxoSmithKline Pakistan Limited

d536.4-d_HOkM13nWO1wOCq_pZW0BYlsBGjOPGrGIo5S345c.lIQ0WL9ZrR3nTTl0RZu4PCtWKR45awHoeff91ueFsq61tzl7mV6WD59IOw~07dbff49ca238cfa45a3857dfc79d899

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +62%
+4.04%
+3.97%
-1.12%
-3%
+12.65%
-3.77%
+23.18%
-11.3%
+0.7%
Average +8.73%
Weighted average by Cap. +3.07%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
315.00PKR
Average target price
510.00PKR
Spread / Average Target
+61.90%
High Price Target
510.00PKR
Spread / Highest target
+61.90%
Low Price Target
510.00PKR
Spread / Lowest Target
+61.90%

Analyst Consensus Detail

Analyst consensus - GlaxoSmithKline Pakistan Limited

Consensus revision (last 18 months)

Consensus revision (last 18 months) - GlaxoSmithKline Pakistan Limited
  1. Stock Market
  2. Stocks
  3. GLAXO Stock
  4. Consensus GlaxoSmithKline Pakistan Limited